Navigation Links
Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial
Date:3/25/2009

h and development projects, the efficacy of REOLYSIN as a cancer treatment, the tolerability of REOLYSIN outside a controlled test, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN, uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements, except as required by applicable laws.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech(R) Inc. Collaborators Present Reovirus Research at Replicating Oncolytic Virus Meeting
2. Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial
3. Oncolytics Biotech(R) Inc. Collaborators Update Combination REOLYSIN(R) and Docetaxel Trial Results at Replicating Oncolytic Virus Meeting
4. Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting
5. Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008
6. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering North America
7. Oncolytics Biotech Inc. Announces Issuance of 31st U.S. Patent
8. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study
9. Media Advisory - Oncolytics Biotech Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference
10. Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data
11. Oncolytics Biotech Inc. Announces U.S. Phase II Sarcoma Clinical Trial Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Having access to safe drinking water ... in many corners of the globe. It’s a major ... northwestern Bolivia where many have been sickened by unclean ... University’s School of Engineering has been working to improve ... “the united college for the peasants.” A branch university ...
(Date:10/31/2014)... Edwardsville, Ill. (PRWEB) October 31, 2014 ... Edwardsville’s Department of Historical Studies within the College of ... at SIUE to record the history of alcohol-based fuels ... politicians, and many others have been working to build ... an important but overlooked aspect of the state's agricultural ...
(Date:10/31/2014)... 31, 2014 Brady (NYSE:BRC), ... today announced a new video testimonial on ... the video, a research technician at the BloodCenter of ... to labeling and storing hundreds of thousands of samples, ... her research. , “At Brady, we design our label ...
(Date:10/31/2014)... -- Atlanta-based Intellimedix could make a positive contribution to ... by suggesting a new, computational approach for investigating ... Computational Systems Biology have spent years developing computer ... existing drugs through systematic repurposing, and their technology ... Ebola. Logo - http://photos.prnewswire.com/prnh/20141030/155702LOGO ...
Breaking Biology Technology:Fairfield University School of Engineering project reduces illness in rural community 2Fairfield University School of Engineering project reduces illness in rural community 3SIUE History Prof Manuel Working on Biofuels Book with NCERC 2SIUE History Prof Manuel Working on Biofuels Book with NCERC 3Brady Debuts New Lab Label Testimonial Video 2Atlanta-Based Intellimedix May Help Solve Ebola With Computer Algorithms 2
... Aug. 29 Pharmos Corporation,(Nasdaq: PARS ) ... will,cease operations in Rehovot, Israel, and manage those ... US headquarters in Iselin, New,Jersey., The research ... library,of compounds, including preclinical development of PRS-639,058 for,neuropathic ...
... SAN DIEGO, Aug. 28 Orexigen(R) Therapeutics,Inc. (Nasdaq: ... central nervous system disorders, including obesity, today announced,that the ... BioCentury Newsmakers in the Biotech Industry ... Millennium Broadway Hotel, New York, UBS Global Life ...
... Enerkem Inc., a leading second,generation biofuels technology ... Vice-Presidents to its executive team: Mr. Denis ... Labrie,Vice-President, Government Affairs and Communications., "I ... to our management,team," said Mr. Vincent Chornet, ...
Cached Biology Technology:Pharmos Corporation Announces That it Will Cease Operations in Israel 2Enerkem Expands Executive Management Team 2
(Date:10/31/2014)... Dr. John Schoggins , Assistant Professor of Microbiology at ... Innovator Award from the National Institutes of Health (NIH) ... harbor numerous viruses without becoming sick. , Dr. ... one of 85 awards given under the High Risk/High ... New Innovator Awards were created to support highly creative ...
(Date:10/31/2014)... key steps involved in programmed cell death, offering new ... and neurodegenerative diseases. , The research teams from ... discover the three-dimensional structure of a key cell death ... how it causes cell death. Their studies were published ... Proceedings of the National Academy of Sciences ...
(Date:10/31/2014)... Oct. 30, 2014  HITLAB SM , a ... announce its inaugural HITLAB Innovators Summit SM ... Library. HITLAB will partner with the Clinton Foundation,s ... Health, ProtoHack, Columbia Business School Alumni Club of ... Industrial Engineering and Operations Research, bringing together leaders ...
Breaking Biology News(10 mins):UT Southwestern Microbiologist awarded prestigious NIH research grant 2A matter of life and death: Cell death proteins key to fighting disease 2HITLAB Announces Inaugural HITLAB Innovators Summit 2HITLAB Announces Inaugural HITLAB Innovators Summit 3
... promising new technique to ensure complete tumor removal at ... of Radiology. , Researchers used light waves in a ... examine excised breast tissue and determine if the removed ... This technology has the potential to eliminate the need ...
... different species, evolution whizzes along. As different species ... environment and prosper. It happens in marine sediments, ... in precancerous tumors, too. , In a study ... Ph.D., a researcher at The Wistar Institute, and ...
... a natural mechanism to get inside cells and grow, researchers ... millions of receptors on the cell's surface routinely do after ... Chair in Oncologic Pathology at the Medical College of Georgia. ... 23 by Proceedings of the National Academy of Sciences. , ...
Cached Biology News:Terahertz imaging may reduce breast cancer surgeries 2Researchers create pigs that produce heart-healthy omega-3 fatty acids 2Common bacteria pirate natural mechanism to get inside cells 2
... Fiberboard boxes are ideal for use in refrigerators, freezers, ... racks. Four vibrant colors allow for color coding to ... liquid nitrogen drainage or promote cool air circulation. Supplied ... holds 81 tubes. Box dimensions: 13 x ...
Sterile glass 5 mm beads that make spreading bacterial and yeast cultures easy. Can be washed, autoclaved and reused....
Similar to proteasome (prosome, macropain) 26S subunit, ATPase, 1 Antigen: Recombinant Protein...
RABBIT ANTI AMPHOTERIN...
Biology Products: